Switch to:

Regeneron Pharmaceuticals EV-to-EBIT

: 19.72 (As of Today)
View and export this data going back to 1991. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Regeneron Pharmaceuticals's Enterprise Value is $64,589 Mil. Regeneron Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $3,276 Mil. Therefore, Regeneron Pharmaceuticals's EV-to-EBIT for today is 19.72.

NAS:REGN' s EV-to-EBIT Range Over the Past 10 Years
Min: -108.7   Med: 24.6   Max: 1948.5
Current: 19.72

-108.7
1948.5

During the past 13 years, the highest EV-to-EBIT of Regeneron Pharmaceuticals was 1948.50. The lowest was -108.70. And the median was 24.60.

NAS:REGN's EV-to-EBIT is ranked higher than
69% of the 241 Companies
in the Biotechnology industry.

( Industry Median: 37.94 vs. NAS:REGN: 19.72 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Regeneron Pharmaceuticals's Enterprise Value for the quarter that ended in Jun. 2020 was $65,197 Mil. Regeneron Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $3,276 Mil. Regeneron Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 was 5.02%.


Regeneron Pharmaceuticals EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Regeneron Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.29 28.69 18.90 14.96 15.82

Regeneron Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.33 12.59 15.82 19.96 19.90

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Regeneron Pharmaceuticals EV-to-EBIT Distribution

* The bar in red indicates where Regeneron Pharmaceuticals's EV-to-EBIT falls into.



Regeneron Pharmaceuticals EV-to-EBIT Calculation

Regeneron Pharmaceuticals's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=64589.200/3276.1
=19.72

Regeneron Pharmaceuticals's current Enterprise Value is $64,589 Mil.
Regeneron Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was 776.3 (Sep. 2019 ) + 896.5 (Dec. 2019 ) + 674.7 (Mar. 2020 ) + 928.6 (Jun. 2020 ) = $3,276 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Regeneron Pharmaceuticals  (NAS:REGN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Regeneron Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2020 ) =EBIT / Enterprise Value (Q: Jun. 2020 )
=3276.1/65196.68585
=5.02 %

Regeneron Pharmaceuticals's Enterprise Value for the quarter that ended in Jun. 2020 was $65,197 Mil.
Regeneron Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was 776.3 (Sep. 2019 ) + 896.5 (Dec. 2019 ) + 674.7 (Mar. 2020 ) + 928.6 (Jun. 2020 ) = $3,276 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Regeneron Pharmaceuticals EV-to-EBIT Related Terms


Regeneron Pharmaceuticals EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)